CVS Health (CVS) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
CVS Health Reports Second Quarter Results
August 8, 2018 6:55 AM EDTWOONSOCKET, R.I., Aug. 8, 2018 /PRNewswire/ --
Second Quarter Year-over-Year Highlights:
Net revenues increased 2.2% to $46.7 billion Same store prescription volume growth of 9.5% GAAP earnings (loss) per share from continuing operations of $(2.52), including a $3.9 billion, or $(3.85) per share, goodwill impairment charge related to the Long-term Care ("LTC") business Adjusted EPS of $1.69Year-to-date Highlights:
Generated cash flow from operations of $5.3 billion; free cash flow of $4.4 billion2018 Full Year Guidance:
Revised full year GAAP diluted... More